论文部分内容阅读
中国疾病预防控制中心与北京生物制品研究所联合研制的DNA—天坛痘苗复合型艾滋病疫苗近日开始在北京协和医院进行第一组志愿者的疫苗接种。这意味着我国具有自主知识产权的艾滋病疫苗开始进行Ⅰ期临床试
DNA-Tiantan vaccinia combined AIDS vaccine jointly developed by China Center for Disease Control and Prevention and Beijing Institute of Biological Products recently started the vaccination of the first group of volunteers in Peking Union Medical College Hospital. This means that our country has independent intellectual property rights of AIDS vaccine began Phase Ⅰ clinical trial